- Children under the age of 16 with gender dysphoria are unlikely to give informed consent to undergo treatment with puberty-blocking medications.
- The UK’s Supreme Court ruled today after a 23-year-old, who regretted after undergoing treatment, took the case to court.
- Lars Sandman, professor of health care ethics at Linköping University, is surprised by the news.
Source: ICELAND NEWS